Intersectionality, a term introduced more than 30 years ago, describes how social categorizations such as race, class, gender, and other social characteristics “intersect” and overlap in the experiences of marginalized groups. In 2015, Patrick Grzanka was looking for a way to bring together researchers on campus who study these intersections—and the Intersectionality Community of Scholars was created.
Recognitions, September 4
Jay Whelan, head of UT’s Department of Nutrition, has been recognized with the Golden Achievement Award by the World Acrobatics Society and induction into the Gallery of Legends Hall of Fame.
The award is given to accomplished athletes who have gone on to have successful careers outside of their athletic accomplishments.
Faculty Spotlight: Gregory L. Stuart, Psychology
Professor Greg Stuart’s research has a particular emphasis on the role of substance use and abuse in intimate partner violence. His goal for his lab is to create a more peaceful world with healthier relationships by tackling the prevalence of physical, psychological, sexual, and cyber aggression, as well as substance abuse.
Psychologist Looks at How We Find Common Ground
When the fall semester begins, Garriy Shteynberg, associate professor of psychology, will lead a three-year study to examine how Americans’ social and political attitudes have grown more extreme over the past 20 years.
The project was awarded a $351,339 grant from the National Science Foundation in May and is expected to conclude in 2021.
The research is a collaboration among scientists who hold divergent views about how attitudes grow more extreme. In all, the research team will work together on 12 experiments—discussing every aspect of the study design, execution, and analysis with the goal of reaching a joint understanding of the results.
Read more about the study at news.utk.edu.
Breathing Problems Linked to Drug that Treats Opioid Addiction
A drug used to treat opioid addiction could cause breathing problems in some obese patients, according to a new study from UT scientists.
Buprenorphine is a Schedule III drug with a lower abuse potential than methadone. It is one of three drugs approved by the US Food and Drug Administration to help patients undergoing treatment for opioid abuse. The UT study found that the drug impairs the ability of obese mice to vary their breathing. These findings in mice may encourage similar studies in humans, since the ability to vary breathing helps us achieve tasks such as climbing stairs and respond to challenges such as disease and surgical stress.
The discovery of the drug’s previously unknown side effect could help clinicians improve patient care, said the study’s lead author, Ralph Lydic, Robert H. Cole Endowed Professor of Neuroscience in the UT Department of Psychology and the Department of Anesthesiology at UT Medical Center.
Continue reading about the study at news.utk.edu.